AXGN logo

AxoGen (AXGN) Company Overview

Profile

Full Name:

Axogen, Inc.

Sector:

Healthcare

Country:

United States

IPO:

December 17, 1986

Indexes:

Not included

Description:

AxoGen, Inc. is a medical technology company specializing in the development and commercialization of technologies for the regeneration and restoration of peripheral nerves. It was founded in 2002. The company's headquarters are located in Alachua, Florida, USA. The company creates nerve connectors, soft tissue membranes, and also uses the AVANCE cellular transplant technology to mimic the human nerve. The company's products are used for treating a wide range of peripheral nerve injuries by plastic surgeons, orthopedic surgeons, maxillofacial surgeons, and others. Axogen, Inc. owns or is the exclusive licensee of around 20 US patents and approximately 70 international patents, with about 15 US patent applications pending.

Key Details

Price

$19.89

Annual Revenue

$159.01 M(+14.74% YoY)

Annual EPS

-$0.51(+26.09% YoY)

Annual ROE

-22.08%

Beta

1.24

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Jan 27, 2010
Splits

Next split:

N/A

Recent split:

Jul 11, 1994

Analyst ratings

Recent major analysts updates

Feb 3, 25 Canaccord Genuity
Buy
Aug 9, 24 JMP Securities
Market Outperform
Jul 1, 24 Raymond James
Outperform
Jun 20, 24 Canaccord Genuity
Buy
Jan 19, 24 Cantor Fitzgerald
Overweight
Dec 7, 23 Canaccord Genuity
Buy
Oct 16, 23 Leerink Partners
Outperform
Sep 26, 23 Cantor Fitzgerald
Overweight
Aug 22, 23 Cantor Fitzgerald
Overweight
May 10, 23 JMP Securities
Market Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for AxoGen?
  • Does AxoGen pay dividends?
  • What sector is AxoGen in?
  • What industry is AxoGen in?
  • What country is AxoGen based in?
  • When did AxoGen go public?
  • Is AxoGen in the S&P 500?
  • Is AxoGen in the NASDAQ 100?
  • Is AxoGen in the Dow Jones?
  • When was AxoGen's last earnings report?
  • When does AxoGen report earnings?
  • Should I buy AxoGen stock now?

What is the ticker symbol for AxoGen?

The ticker symbol for AxoGen is NASDAQ:AXGN

Does AxoGen pay dividends?

No, AxoGen does not pay dividends

What sector is AxoGen in?

AxoGen is in the Healthcare sector

What industry is AxoGen in?

AxoGen is in the Medical Devices industry

What country is AxoGen based in?

AxoGen is headquartered in United States

When did AxoGen go public?

AxoGen's initial public offering (IPO) was on December 17, 1986

Is AxoGen in the S&P 500?

No, AxoGen is not included in the S&P 500 index

Is AxoGen in the NASDAQ 100?

No, AxoGen is not included in the NASDAQ 100 index

Is AxoGen in the Dow Jones?

No, AxoGen is not included in the Dow Jones index

When was AxoGen's last earnings report?

AxoGen's most recent earnings report was on Feb 25, 2025

When does AxoGen report earnings?

The date for AxoGen's next earnings report has not been announced yet

Should I buy AxoGen stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions